Thus, the strong synergistic effect observed when lapatinib and YM155 were combined was inherent to ABCB1 expressing neuroblastoma cells, where ABCB1 inhibition by lapatinib augmented YM155 concentrations and cytotoxicity. This evidence concerns the gene ABCB1 and neuroblastoma.